Get the Stockscreener App
0.811
1.38%
0.011
After Hours:
.83
0.019
+2.34%
Applied Dna Sciences Inc stock is traded at $0.811, with a volume of 467.85K.
It is up +1.38% in the last 24 hours and down -55.68% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.80
Open:
$0.79
24h Volume:
467.85K
Relative Volume:
0.47
Market Cap:
$1.01M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-1.4745
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-26.27%
1M Performance:
-55.68%
6M Performance:
-94.88%
1Y Performance:
-99.76%
1-Day Range:
$0.77
$0.83
1-Week Range:
$0.77
$1.32
52-Week Range:
$0.77
$376.30
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.811 | 1.01M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com UK
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Applied DNA seeks NY approval for bird flu test By Investing.com - Investing.com South Africa
Applied DNA Seeks New York Approval for H5 Bird Flu Test - MarketScreener
Applied DNA Sciences submits request to NYSDOH for H5 bird flu LDT approval - TipRanks
Applied DNA seeks NY approval for bird flu test - Investing.com Australia
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test - ACCESS Newswire
New H5 Bird Flu Test Advances: Applied DNA's Dual-Detection System Nears Market Launch - Stock Titan
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27 - Business Wire
Just Style - Just Style
APDN Stock Plummets: Opportunity or Warning? - timothysykes.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Galveston County Daily News
Applied DNA announces 1-for-50 reverse stock split - MSN
APDN stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences to Implement 1-for-50 Reverse Stock Split; Shares Fall -March 12, 2025 at 11:14 am EDT - Marketscreener.com
Applied DNA announces 1-for-50 reverse stock split By Investing.com - Investing.com Australia
Applied DNA Sciences Says 1-For-50 Reverse Stock Split Of Issued And Outstanding Common Stock Effective March 14 - Marketscreener.com
APDN stock plunges to 52-week low of $0.09 amid market challenges By Investing.com - Investing.com South Africa
Applied DNA Sciences announces 1-for-50 reverse stock split - TipRanks
Applied DNA Sciences Announces Major Share Consolidation to Maintain Nasdaq Listing - StockTitan
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):